Intravenous granisetron for food protein–induced enterocolitis syndrome in Japanese children: A retrospective study
Pediatrics International · 2026-01 · 68 (1)
DOI: 10.1111/ped.70368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 26.03.2026. Verfasst von Doi Masaaki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Higashiosaka City Medical Center, Higashiosaka, Osaka, Japan. Hauptthemen laut MEDLINE: Granisetron, Enterocolitis, Food Hypersensitivity, Antiemetics. Die Arbeit nennt 24 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Food protein–induced enterocolitis syndrome (FPIES) is a non‐IgE‐mediated gastrointestinal food allergy characterized by delayed‐onset vomiting. Although ondansetron has demonstrated efficacy in managing FPIES‐related symptoms, its use remains off‐label in Japan. Granisetron hydrochloride (GH), another 5‐HT 3 receptor antagonist, is approved in Japan for postoperative and chemotherapy‐induced nausea and vomiting in children and is widely used in pediatric clinical settings. However, its use in FPIES has not been fully evaluated. This study aimed to assess the effectiveness and safety of intravenous GH in Japanese children undergoing oral food challenges (OFCs) for FPIES.
Methods
This retrospective study included pediatric patients who underwent OFCs for suspected or confirmed FPIES between January 2019 and September 2024 at a single center in Japan. Patients who developed vomiting received intravenous GH (40 μg/kg) and were subsequently monitored for symptom resolution, recurrence, the need for additional interventions, and any adverse events.
Results
Among the 73 OFCs performed in 50 patients, 20 (27.4%) yielded a positive result, defined by the occurrence of vomiting. Of these, 18 cases from 16 patients received intravenous GH, and 16 OFCs from 14 patients were included in the final analysis. Vomiting resolved completely in 12 cases (75.0%), while four (25.0%) experienced only one additional vomiting episode. No cases required further antiemetic therapy or fluid resuscitation, and no GH‐related adverse events were observed.
Conclusions
Intravenous GH was well‐tolerated and may be effective in managing vomiting associated with FPIES during OFCs. These findings suggest that GH may be a practical therapeutic option, warranting further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Higashiosaka City Medical Center, Higashiosaka, Osaka, Japan.
- Department of Pediatrics, Minaminara General Medical Center, Oyodo-cho, Yoshino-gun, Nara, Japan.
ORCID-Profile: Doi Masaaki
Zitieren
APA
Masaaki, D., Nayu, I., Takuya, N., Ryuuki, Y., Ryunosuke, N., Tsuyoshi, M., Daiki, S., Rikiho, T., Maho, F., Satoshi, Y., Ryouta, Y., Yoshiko, Y., & Yasuko, F. (2026). Intravenous granisetron for food protein–induced enterocolitis syndrome in Japanese children: A retrospective study. Pediatrics International, 68(1). https://doi.org/10.1111/ped.70368
Vancouver
Masaaki D, Nayu I, Takuya N, Ryuuki Y, Ryunosuke N, Tsuyoshi M, et al. Intravenous granisetron for food protein–induced enterocolitis syndrome in Japanese children: A retrospective study. Pediatrics International. 2026;68(1). doi:10.1111/ped.70368
BibTeX
@article{Masaaki2026,
author = {Masaaki, Doi and Nayu, Iwakoshi and Takuya, Nogami and Ryuuki, Yano and Ryunosuke, Nakayama and Tsuyoshi, Mandai and Daiki, Shinguryo and Rikiho, Tsujimoto and Maho, Fujino and Satoshi, Yanagino and Ryouta, Yoshida and Yoshiko, Yoshimura and Yasuko, Furuichi},
title = {Intravenous granisetron for food protein–induced enterocolitis syndrome in Japanese children: A retrospective study},
journal = {Pediatrics International},
year = {2026},
volume = {68},
number = {1},
doi = {10.1111/ped.70368}
}
EUVIMED